Many patients need both brow lift and blepharoplasty | Live-streaming plastic surgery provides opportunity to educate the public | Plastic surgeon: Explain costs carefully to patients with high deductibles
Patients seeking eye area rejuvenation need a brow lift if the brow is below the brow bone and an upper blepharoplasty if their eyelids appear heavy or impair vision, says facial plastic surgeon Andrew Miller. Many patients need both, and eyelid ptosis can be corrected at the same time, Miller says.
Ashley Devonna, a 24-year-old beauty blogger, is live-streaming her breast enhancement surgery, and plastic surgeon Farah Khan sees it as an opportunity to educate the public. "I feel like if we can actually educate the public about what it is that we do and how it can help them, then I think it's great," Khan said, adding: "Plastic surgery is not for everyone."
A growing number Americans are covered by high-deductible health insurance plans, and plastic surgeons and hospitals must carefully explain out-of-pocket costs to these patients, says plastic surgeon Vikram Reddy. Submitting claims to insurers is also becoming more of a challenge, says plastic surgeon Mark Komorowski.
More teenagers are seeking plastic surgery and aesthetic procedures, and knowing when such procedures are appropriate is not always easy, writes Rod Rohrich, chairman of the Department of Plastic Surgery at The University of Texas Southwestern Medical Center. He reviews common procedures sought by teens as well as motivating factors, and suggests guidelines plastic surgeons should consider.
A woman who provided anesthetic services for Denver area plastic surgeons is being sued by a patient who claims her botched liposuction procedure caused heart failure, and the case is prompting broader questions about regulation and oversight of outpatient plastic surgery. Plastic surgery centers in Colorado are not subject licensing and inspection requirements that apply to other ambulatory surgical centers.
A blood test that detects DNA fragments released by malignant tumors accurately diagnosed 71% of early-stage colon cancers, 68% of early-stage ovarian cancers and 59% of early-stage breast and lung cancers in 200 patients previously diagnosed with cancer; and yielded no false positives in 44 cancer-free volunteers, researchers reported in Science Translational Medicine. More work on the assay is needed, but the ability to diagnose cancer at very early stages could save lives, says lead researcher Victor Velculescu.